No Detail Found!

Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma

Author(s)
Maryam Mumtaz Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Tahir Hassan Chandio Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Mohammad Khurram Shahzad Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Nazia Hanif Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Sarah Anwar Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Saira Rafique Department of Dermatology, Sheikh Zaid Hospital,Rahim Yar Khan,Pakistan
Abstract
Objective: To compare the e cacy of intradermal platelet-rich-plasmvas. intradermal tranexamic acid in treatment of melasma. Study Design: Non-randomised controlled trial. Place and Duration of Study: Sheikh Zayed Hospital, Rahim Yar Khan from 1st October 2019 to 30th April 2020. Methodology: Cases of melasma from either gender with age 20-40 years, were included. Diagnosis of melasma was made clinically on the basis of hyperpigmentation at sun-exposed areas and by Wood s lamp. Severity was labelled on the basis of melasma area and severity index (MASI) score. Cases in group A were managed with 1 ml ofintradermal platelet-rich plasma (PRP) and those in group B were o ered intradermal tranexamic acid in a dose of 4 mg. The treatment was o ered everyth 4 week and for a total period of 12 weeks; and nal outcome was seen at 24th week. At every visit, the cases were noted for their mean MASI score. Results: In this study, there were a total of 64 cases, 32 in each group. There were 19 (59.38%) males in group A and 16 (50%) in group B (p=0.61). Mean age in group A and B was 24.63 ± 9.87 vs. 23.94 ± 8.93 years (p= 0.76). Mean MASI score at baseline was 29.84 ± 5.14vs. 29.56 ± 4.39, p=0.21. MASI was signi cantly better in group A at 4 weeks where score was 29.44 ± 5.35 vs. 28.69 ± 4.10, p=0.01. Mean MASI was 12.81 ± 1.78 vs. 18.38 ± 3.50, p=00001 at 12 weeks and 8.72 ± 3.40 vs. 14.97±4.33, p=0.02 at 24 weeks in group A and B, respectively. Conclusion: Intradermal PRP is signi cantly better than intradermal tranexamic acid in management of melasma.
Publication Details
Page(s) 502-505
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 5, Year: 2021

Request the full text from PASTIC

Keywords
MASI, tranexamic acid, Melasma, PRP
0

Citations

0

Downloads

59

Views